NEW YORK, July 25, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of USANA Health Sciences, Inc. (NASDAQ: USNA) ("USANA Health " or the "Company") who purchased USANA common stock between October 23, 2012 and July 23, 2013 (the "Class Period"). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 237.
The investigation concerns whether USANA Health and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On July 23, 2013, USANA Health announced that the Securities and Exchange Commission (SEC), is conducting an investigation, which appears to involve possible issues regarding trading in the Company's stock during 2012 by certain of the Company's officers and directors including the Company's Chairman. On this news, the shares of USANA Health fell $6.56, or 8.14% percent, to $73.99 on July 24, 2013.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT: Robert S. Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP email@example.com
SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP